Quinn Candice M, Vachhani Jay J, Thielman Emily J, Kulinski Devon, Sonstroem Anneka, Henry James A, Smith Sherri L
Durham VA Health Care System, Durham, North Carolina.
Department of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, Durham, North Carolina.
Semin Hear. 2023 Jun 28;45(1):123-140. doi: 10.1055/s-0043-1770153. eCollection 2024 Feb.
Tinnitus acoustic therapy is defined as any use of sound where the intent is to alter the tinnitus perception and/or the reactions to tinnitus in a clinically beneficial way. The parameters of sound that may cause beneficial effects, however, are currently only theorized with limited data supporting their effectiveness. Residual inhibition is the temporary suppression or elimination of tinnitus that is usually observed following appropriate auditory stimulation. Our pilot study investigated the effects of a therapeutic acoustic stimulus that was individually customized to maximize residual inhibition of tinnitus and extend its duration to determine if there could be a sustained suppression of the tinnitus signal (i.e., reduced tinnitus loudness) and a reduction in the psychological and emotional reactions to tinnitus. This pilot study had two objectives: (1) to evaluate the feasibility of residual inhibition technique therapy through daily use of hearing aids and (2) to determine its effects by measuring reactionary changes in tinnitus with the Tinnitus Functional Index (TFI) and perceptual changes in tinnitus loudness. A total of 20 adults (14 males, 6 females; mean age: 58 years, SD = 12.88) with chronic tinnitus were enrolled in a four-visit study that consisted of the following: (1) baseline visit and initiation of the intervention period, (2) a 1-month postintervention visit, (3) 2-month postintervention visit and initiation of a wash-out period, and (4) a 3-month visit to assess the wash-out period and any lasting effects of the intervention. The intervention consisted of fitting bilateral hearing aids and creating an individualized residual inhibition stimulus that was streamed via Bluetooth from a smartphone application to the hearing aids. The participants were instructed to wear the hearing aids and stream the residual inhibition stimulus all waking hours for the 2-month intervention period. During the wash-out period, the participants were instructed to use the hearing aids for amplification, but the residual inhibition stimulus was discontinued. At all visits, the participants completed the TFI, study-specific self-report measures to document perceptions of tinnitus, a psychoacoustic test battery consisting of tinnitus loudness and pitch matching, and a residual inhibition test battery consisting of minimum masking and minimum residual inhibition levels. At the end of the trial, participants were interviewed about the study experience and acceptability of the residual inhibition treatment technique. Repeated measures analyses of variance (ANOVA) were conducted on the two main outcomes (TFI total score and tinnitus loudness) across all four visits. The results showed a significant main effect of visit on the TFI total score ( < 0.0001). Specifically, the results indicated a significant reduction in TFI total scores from baseline to the 1-month post-intervention period, which remained stable across the 2-month post-intervention period and the wash-out period. The ANOVA results did not show a significant change in tinnitus loudness as a function of visit ( = 0.480). The majority of the participants reported a positive experience with the study intervention at their exit interview. This pilot study demonstrated that residual inhibition as a sound therapy for tinnitus, specifically through the daily use of hearing aids, was feasible and acceptable to individuals suffering from chronic tinnitus. In addition, participants showed improvement in reactions to tinnitus as demonstrated by sustained reduction in TFI scores on average over the course of the treatment period. Achieving residual inhibition may also provide patients a feeling of control over their tinnitus, and this may have a synergistic effect in reducing the psychological and emotional distress associated with tinnitus. There was no significant reduction in long-term tinnitus loudness resulting from the residual inhibition treatment; however, the current pilot study may not have had sufficient power to detect such a change. The combination of tinnitus suppression and improved psychosocial/emotional reactions to tinnitus may result in a better quality of life in both the short and long term. A larger-scale study is needed to determine the validity of using residual inhibition as a clinical therapy option and to ascertain any effects on both perception and reactions to tinnitus.
耳鸣声学疗法被定义为以临床有益的方式使用声音来改变耳鸣感知和/或对耳鸣的反应。然而,可能产生有益效果的声音参数目前只是理论推测,仅有有限的数据支持其有效性。残余抑制是指在适当的听觉刺激后通常观察到的耳鸣的暂时抑制或消除。我们的初步研究调查了一种治疗性声学刺激的效果,该刺激是个性化定制的,以最大限度地增强耳鸣的残余抑制并延长其持续时间,以确定是否可以持续抑制耳鸣信号(即降低耳鸣响度)以及减少对耳鸣的心理和情绪反应。这项初步研究有两个目标:(1)通过日常使用助听器评估残余抑制技术疗法的可行性;(2)通过使用耳鸣功能指数(TFI)测量耳鸣的反应性变化以及耳鸣响度的感知变化来确定其效果。共有20名患有慢性耳鸣的成年人(14名男性,6名女性;平均年龄:58岁,标准差 = 12.88)参加了一项为期四次就诊的研究,该研究包括以下内容:(1)基线就诊和干预期开始;(2)干预后1个月就诊;(3)干预后2个月就诊和洗脱期开始;(4)3个月就诊以评估洗脱期和干预的任何持久影响。干预措施包括佩戴双侧助听器,并创建一个个性化的残余抑制刺激,该刺激通过蓝牙从智能手机应用程序传输到助听器。参与者被指示在2个月的干预期内,醒着的所有时间都佩戴助听器并传输残余抑制刺激。在洗脱期,参与者被指示使用助听器进行放大,但停止传输残余抑制刺激。在所有就诊时,参与者完成TFI、记录耳鸣感知的特定研究自我报告测量、由耳鸣响度和音高匹配组成的心理声学测试组,以及由最小掩蔽和最小残余抑制水平组成的残余抑制测试组。在试验结束时,对参与者进行了关于研究体验和残余抑制治疗技术可接受性的访谈。对所有四次就诊的两个主要结果(TFI总分和耳鸣响度)进行了重复测量方差分析(ANOVA)。结果显示就诊对TFI总分有显著的主效应(<0.0001)。具体而言,结果表明从基线到干预后1个月期间TFI总分显著降低,在干预后2个月期间和洗脱期保持稳定。ANOVA结果未显示耳鸣响度随就诊有显著变化( = 0.480)。大多数参与者在退出访谈中报告对研究干预有积极体验。这项初步研究表明,残余抑制作为一种耳鸣的声音疗法,特别是通过日常使用助听器,对患有慢性耳鸣的个体是可行且可接受的。此外,如治疗期间平均TFI分数持续降低所示,参与者对耳鸣的反应有所改善。实现残余抑制也可能使患者对其耳鸣有一种控制感,这可能在减少与耳鸣相关的心理和情绪困扰方面具有协同作用。残余抑制治疗并未使长期耳鸣响度显著降低;然而,当前的初步研究可能没有足够的能力检测到这种变化。耳鸣抑制与对耳鸣的心理社会/情绪反应改善相结合,可能在短期和长期内都带来更好的生活质量。需要进行更大规模的研究来确定使用残余抑制作为临床治疗选择的有效性,并确定其对耳鸣感知和反应的任何影响。